BRPI0406636A - Lentes de contato e métodos e composições de gotas oftálmicas de reumidificação - Google Patents

Lentes de contato e métodos e composições de gotas oftálmicas de reumidificação

Info

Publication number
BRPI0406636A
BRPI0406636A BR0406636-7A BRPI0406636A BRPI0406636A BR PI0406636 A BRPI0406636 A BR PI0406636A BR PI0406636 A BRPI0406636 A BR PI0406636A BR PI0406636 A BRPI0406636 A BR PI0406636A
Authority
BR
Brazil
Prior art keywords
contact lenses
rehumidification
compositions
formulations
sym
Prior art date
Application number
BR0406636-7A
Other languages
English (en)
Inventor
James N Cook
Original Assignee
Advanced Medical Optics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc
Publication of BRPI0406636A publication Critical patent/BRPI0406636A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

"LENTES DE CONTATO E MéTODOS E COMPOSIçõES DE GOTAS OFTáLMICAS DE REUMIDIFICAçãO". A presente invenção refere-se a formulações oftálmicas que compreendem o ácido hialurónico (hialuronato de sódio) como o primeiro ingrediente ativo demulcente, complexo de óxi-cloro estabilizado (disponível comercialmente como OcuPure¬ <sym>¬ da Advanced Medical Optics, Purite <sym> da Aliergan e Purogene da Biocide) para eficácia conservante, sais balanceados que imitam a película de lágrima e borato de sódio como um tampão. Em uma modalidade, as formulações estáveis de preferidas podem ser usadas no olho humano com ou sem lentes de contato. Em uma outra modalidade, as formulações de preferência também podem ser usadas como uma solução para o armazenamento e o condicionamento de lentes de contato em seguida à desinfecção.
BR0406636-7A 2003-01-08 2004-01-08 Lentes de contato e métodos e composições de gotas oftálmicas de reumidificação BRPI0406636A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43884303P 2003-01-08 2003-01-08
US43885703P 2003-01-08 2003-01-08
PCT/US2004/000298 WO2004062660A1 (en) 2003-01-08 2004-01-08 Contact lens and eye drop rewetter compositions and their uses

Publications (1)

Publication Number Publication Date
BRPI0406636A true BRPI0406636A (pt) 2005-12-06

Family

ID=32718011

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406636-7A BRPI0406636A (pt) 2003-01-08 2004-01-08 Lentes de contato e métodos e composições de gotas oftálmicas de reumidificação

Country Status (8)

Country Link
US (3) US20040137079A1 (pt)
EP (1) EP1581211A1 (pt)
JP (1) JP2006516032A (pt)
AU (1) AU2004204734B2 (pt)
BR (1) BRPI0406636A (pt)
CA (1) CA2512320A1 (pt)
TW (1) TWI339747B (pt)
WO (1) WO2004062660A1 (pt)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
KR101131056B1 (ko) 2003-06-13 2012-04-23 알콘, 인코퍼레이티드 시너지성의 2개의 폴리머 배합물을 포함하는 안과용 조성물
US7947295B2 (en) 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7722808B2 (en) 2003-09-12 2010-05-25 Novartis Ag Method and kits for sterilizing and storing soft contact lenses
US20050202983A1 (en) * 2004-03-12 2005-09-15 Erning Xia Prevention of loss of tight cell junctions using carbohydrate-containing compositions
US8288362B2 (en) * 2004-05-07 2012-10-16 S.K. Pharmaceuticals, Inc. Stabilized glycosaminoglycan preparations and related methods
JP2007536277A (ja) * 2004-05-07 2007-12-13 エスケイ ファーマシューティカルズ インコーポレイテッド 安定化されたヒアルロナン調製物及びその方法
US20080307751A1 (en) * 2004-10-01 2008-12-18 Newman Stephen D Contact Lens Package Solution
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US9297928B2 (en) 2004-11-22 2016-03-29 Johnson & Johnson Vision Care, Inc. Ophthalmic compositions comprising polyether substituted polymers
CN103933614B (zh) 2005-02-14 2016-03-02 庄臣及庄臣视力保护公司 舒适的眼用器件及其制造方法
TW200722109A (en) * 2005-03-31 2007-06-16 Bausch & Lomb Polysaccharide and polyol composition for treating dry eye and related methods of manufacture and methods of use
ES2285910B1 (es) * 2005-09-08 2008-12-16 Vicente Tormo Maicas Procedimiento para la elaboracion de la formula de hialuronato sodico para la curacion y cicatrizacion de heridas.
US9052529B2 (en) 2006-02-10 2015-06-09 Johnson & Johnson Vision Care, Inc. Comfortable ophthalmic device and methods of its production
WO2008011836A2 (es) 2006-07-25 2008-01-31 Osmotica Corp. Soluciones oftálmicas
US20080095754A1 (en) * 2006-10-18 2008-04-24 Burke Susan E Ophthalmic compositions comprising diglycine
US8138156B2 (en) * 2006-10-18 2012-03-20 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US20080141628A1 (en) * 2006-12-15 2008-06-19 Bausch & Lomb Incorporated Packaging Solutions
US20080166393A1 (en) * 2007-01-05 2008-07-10 Grant Robert K Eye Medication Delivery System
US8759321B2 (en) * 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
JP5643092B2 (ja) 2007-08-31 2014-12-17 ノバルティス アーゲー コンタクトレンズのパッケージング溶液
TWI551305B (zh) 2007-08-31 2016-10-01 諾華公司 相對黏稠封裝溶液之用途
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US8119112B2 (en) * 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US8629099B2 (en) * 2008-03-25 2014-01-14 Bausch & Lomb Incorporated Ophthalmic compositions comprising a dipeptide
WO2010003797A1 (en) * 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
BRPI0916418A2 (pt) 2008-07-15 2017-08-29 Basf Corp Composição, e, método de produção de uma composição de fluido espessada substancialmente não-citotóxica
US20100286010A1 (en) * 2008-09-03 2010-11-11 Erning Xia Ophthalmic Compositions with Hyaluronic Acid
CA2736380C (en) * 2008-09-15 2013-05-28 Bausch & Lomb Incorporated Compositions comprising polymers having amino sugar units and methods of making and using same
US20100178317A1 (en) * 2009-01-09 2010-07-15 Burke Susan E Lens Care Solutions with Hyaluronic Acid
US20100196512A1 (en) 2009-02-04 2010-08-05 Basf Catalyst Llc Treatment of Non-Oral Biological Tissue with Chlorine Dioxide
IT1394223B1 (it) 2009-05-15 2012-06-01 Thea Sas Lab Kit per la valutazione e la selezione personalizzata di lacrime artificiali
JP5601805B2 (ja) * 2009-08-24 2014-10-08 キユーピー株式会社 経口用ドライアイ改善剤、ならびに前記経口用ドライアイ改善剤を含む食品組成物および医薬品組成物
TW201127423A (en) * 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
AT511164A1 (de) 2011-03-03 2012-09-15 Croma Pharma Gmbh Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP3981387A1 (en) 2011-12-07 2022-04-13 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US8664180B2 (en) 2012-02-06 2014-03-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
US8324171B1 (en) 2012-02-06 2012-12-04 Bausch & Lomb Incorporated Ophthalmic compositions containing diglycine
ES2609013T3 (es) * 2012-02-24 2017-04-18 Bausch & Lomb Incorporated Composiciones oftálmicas con ceras naturales alcoxiladas
DK3517100T3 (da) * 2013-02-01 2020-12-14 Allergan Inc Kunstige tårer omfattende natriumhyaluronat og carboxymethylcellulose
WO2016013993A1 (en) 2014-07-25 2016-01-28 Imuneks Farma Llac Sanayi Ve Ticaret A.Ş. Stable preservative free ophthalmic formulations of opioid antagonists
WO2016085885A1 (en) 2014-11-25 2016-06-02 Allergan, Inc. Stabilized omega-3 ophthalmic compositions
CA3002506C (en) 2015-12-03 2020-07-14 Novartis Ag Contact lens packaging solutions
TWI609957B (zh) 2016-06-27 2018-01-01 晶碩光學股份有限公司 用以處理隱形眼鏡之溶液及隱形眼鏡的包裝系統
IT201700009786A1 (it) * 2017-01-30 2018-07-30 For Health Pharma S R L Sostituto lacrimale
JP7104553B2 (ja) * 2018-03-30 2022-07-21 ロート製薬株式会社 眼科組成物
AU2019261437A1 (en) 2018-04-27 2020-12-17 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
CN112741105A (zh) * 2019-10-30 2021-05-04 永胜光学股份有限公司 具有高效抗微生物能力与润滑效果的溶液
TWI821845B (zh) * 2021-12-29 2023-11-11 永勝光學股份有限公司 應用於眼用鏡片的溶液

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
IT1212892B (it) * 1983-10-11 1989-11-30 Della Valle Francesco Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica
US4478189A (en) * 1982-12-08 1984-10-23 Lucas Industries Fuel injection system
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
CA2003198C (en) * 1988-11-29 1995-03-21 Anthony J. Dziabo, Jr. Aqueous ophthalmic solutions and method for preserving same
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
WO2000019981A1 (en) * 1998-10-08 2000-04-13 Karagoezian Hampar L Synergistic antimicrobial, dermatological and ophthalmic preparations containing chlorite and hydrogen peroxide
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
US6592907B2 (en) * 1999-10-04 2003-07-15 Hampar L. Karagoezian Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide
BR0112461A (pt) * 2000-07-14 2003-07-22 Allergan Inc Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
RU2311928C2 (ru) * 2000-07-14 2007-12-10 Аллерган Инк. Композиции, содержащие альфа-2-адренергические агонисты
DE10038955C2 (de) * 2000-08-09 2002-07-11 Infineon Technologies Ag Verfahren zur Herstellung eines Bipolartransistors
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
JP3455852B2 (ja) * 2000-12-26 2003-10-14 株式会社オフテクス 洗眼液組成物
DK1347787T4 (da) * 2001-01-09 2011-01-03 Louis Johan Wagenaar Anvendelse af dexpanthenol i kontaktlinse-plejesammensætninger
AR034371A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
US6982079B2 (en) * 2002-04-26 2006-01-03 Allergan, Inc. Compositions for treating hyperemia

Also Published As

Publication number Publication date
AU2004204734B2 (en) 2008-04-10
EP1581211A1 (en) 2005-10-05
US20050266089A1 (en) 2005-12-01
US20040137079A1 (en) 2004-07-15
AU2004204734A1 (en) 2004-07-29
TW200419217A (en) 2004-10-01
WO2004062660A1 (en) 2004-07-29
CA2512320A1 (en) 2004-07-29
US20050260280A1 (en) 2005-11-24
JP2006516032A (ja) 2006-06-15
TWI339747B (en) 2011-04-01

Similar Documents

Publication Publication Date Title
BRPI0406636A (pt) Lentes de contato e métodos e composições de gotas oftálmicas de reumidificação
ES2374607T3 (es) Composiciones oftálmicas con un tensioactivo anfótero y ácido hialurónico.
JP5877795B2 (ja) コンタクトレンズ用眼科組成物
JP5616620B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP7304282B2 (ja) カラーコンタクトレンズ用眼科組成物
JP2022001579A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP5627294B2 (ja) コンタクトレンズ用眼科組成物
JP2014028857A (ja) メントール類を含有する亜塩素酸類化合物含有水性組成物
BRPI0417175A (pt) composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
JP2003206241A (ja) 眼科用剤
JP6449774B2 (ja) 両性イオン性ソフトコンタクトレンズ用眼科用組成物
JP2023025297A (ja) 摩擦低減用であるコンタクトレンズ用点眼剤、その使用方法、および装用中のコンタクトレンズの摩擦低減方法
JP2010215601A (ja) シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP4442118B2 (ja) 安定な点眼剤
CN105555268B (zh) 阴离子性软隐形眼镜用眼科用组合物
ES2263623T3 (es) Agentes antisepticos.
JP5650864B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2009175731A (ja) グリセリンおよびリン酸化合物を含有する亜塩素酸類化合物含有水性組成物
JPWO2017094508A1 (ja) 眼科組成物
JP2009199074A (ja) ポリオキシエチレンヒマシ油誘導体およびリン酸化合物を含有する亜塩素酸類化合物含有水性組成物
JP5879410B2 (ja) コンタクトレンズ用眼科組成物
JP2006000170A (ja) コンタクトレンズ用組成物
JP6687781B1 (ja) 刺激感が抑制された眼科組成物
WO2020184479A1 (ja) 刺激感が抑制された眼科組成物
JP5768720B2 (ja) 点眼剤

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: ABBOTT MEDICAL OPTICS INC. (US)

Free format text: ALTERADO DE: ADVANCED MEDICAL OPTICS, INC.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B25B Requested transfer of rights rejected

Owner name: ABBOTT MEDICAL OPTICS INC. (US)